News Implants could transform CAR-T therapy into one-day procedur... CAR-T therapies have revolutionised the treatment of some blood cancers, but are costly as well as time- and resource-intensive.
Events Partner Content TCR-based Therapeutics for Solid Tumors Summit Hear from experts at the TCR based Therapeutics Summit
Events Partner Content 2nd ARDS Drug Development Summit Only Industry-Specific Event for ARDS Drug Developers
Events Partner Content 3rd Gamma Delta T Therapies Summit The Only Industry-Specific Event on γδT Therapies
Events Partner Content 3rd B & T Cell-Mediated Autoimmune Disease Drug Development ... Industry-led forum focused on B & T Cell Collaboration
News Merck turns to cardiovascular pipeline for its post-Keytruda... For some years industry observers have been asking what Merck & Co can do to reduce its reliance on blockbuster cancer immunotherapy Keytruda.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.